Hypertrophic cardiomyopathy: Assessment with MR imaging and multidetector CT

Radiographics

Volumn 30, Issue 5, 2010, Pages 1309-1328

  Chun, Eun Ju ^a   Choi, Sang Il ^a   Jin, Kwang Nam ^a   Kwag, Hyon Joo ^b   Kim, Young Jin ^c   Choi, Byoung Wook ^c   Lee, Whal ^d   Park, Jae Hyung ^d  

^a Seoul National University Bundang Hospital   (South Korea)

^b School of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Seoul National University Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ENHANCEMENT; IMAGE SUBTRACTION; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING;

CARDIOMYOPATHY, HYPERTROPHIC; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77957736726     PISSN: 02715333     EISSN: 15271323     Source Type: Journal    
DOI: 10.1148/rg.305095074     Document Type: Article

References (67)

1. Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003;42 (9):1687-1713.
2. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287(10):1308-1320.
3. Marian AJ, Roberts R. Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation 1995;92(5):1336-1347.
4. Soor GS, Luk A, Ahn E, et al. Hypertrophic cardiomyopathy: current understanding and treatment objectives. J Clin Pathol 2009;62(3):226-235.
5. Rickers C, Wilke NM, Jerosch-Herold M, et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005;112(6):855-861.
6. Prasad K, Atherton J, Smith GC, McKenna WJ, Frenneaux MP, Nihoyannopoulos P. Echocardiographic pitfalls in the diagnosis of hypertrophic cardiomyopathy. Heart 1999;82(suppl 3):III8-III15.
7. Pennell DJ, Sechtem UP, Higgins CB, et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J 2004; 25(21):1940-1965.
8. Lima JA, Desai MY. Cardiovascular magnetic resonance imaging: current and emerging applications. J Am Coll Cardiol 2004;44(6):1164-1171.
9. Maron MS, Maron BJ, Harrigan C, et al. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol 2009;54(3):220-228.
10. Nagueh SF, Mahmarian JJ. Noninvasive cardiac imaging in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2006;48(12):2410-2422.
11. Yoshida M, Takamoto T. Left ventricular hypertrophic patterns and wall motion dynamics in hypertrophic cardiomyopathy: an electron beam computed tomographic study. Intern Med 1997;36(4): 263-269.
12. Ghersin E, Lessick J, Litmanovich D, Engel A, Reisner S. Comprehensive multidetector CT assessment of apical hypertrophic cardiomyopathy. Br J Radiol 2006;79 (948): e200-e204.
13. Juergens KU, Wessling J, Fallenberg EM, Mönnig G, Wichter T, Fischbach R. Multislice cardiac spiral CT evaluation of atypical hypertrophic cardiomyopathy with a calcified left ventricular thrombus. J Comput Assist Tomogr 2000;24(5):688-690.
14. Williams TJ, Manghat NE, McKay-Ferguson A, Ring NJ, Morgan-Hughes GJ, Roobottom CA. Cardiomyopathy: appearances on ECG-gated 64-detector row computed tomography. Clin Radiol 2008;63 (4):464-474.
15. Spirito P, Autore C. Management of hypertrophic cardiomyopathy. BMJ 2006;332(7552):1251-1255.
16. Park JH, Kim YM, Chung JW, Park YB, Han JK, Han MC. MR imaging of hypertrophic cardiomyopathy. Radiology 1992;185(2):441-446.
17. Hughes SE. The pathology of hypertrophic cardiomyopathy. Histopathology 2004;44(5):412-427.
18. Hansen MW, Merchant N. MRI of hypertrophic cardiomyopathy. I. MRI appearances. AJR Am J Roentgenol 2007;189(6):1335-1343.
19. Wigle ED. Cardiomyopathy: the diagnosis of hypertrophic cardiomyopathy. Heart 2001;86(6): 709-714.
20. Kansal S, Roitman D, Sheffield LT. Interventricular septal thickness and left ventricular hypertrophy: an echocardiographic study. Circulation 1979;60(5): 1058-1065.
21. Elliott P, McKenna WJ. Hypertrophic cardiomyopathy. Lancet 2004;363(9424):1881-1891.
22. Maron MS, Olivotto I, Zenovich AG, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation 2006;114(21):2232-2239.
23. Luckie M, Khattar RS. Systolic anterior motion of the mitral valve: beyond hypertrophic cardiomyopathy. Heart 2008;94(11):1383-1385.
24. Halpern EJ. Cardiac morphology and function. In: Clinical cardiac CT: anatomy and function. New York, NY: Thieme, 2008; 166-175.
25. Shah JS, Esteban MT, Thaman R, et al. Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy. Heart 2008; 94(10):1288-1294.
26. White RD, Obuchowski NA, Gunawardena S, et al. Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: presurgical and postsurgical evaluation by computed tomography magnetic resonance imaging. Am J Card Imaging 1996;10(1): 1-13.
27. Amano Y, Takayama M, Amano M, Kumazaki T. MRI of cardiac morphology and function after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy. AJR Am J Roentgenol 2004;182(2):523-527.
28. Sakamoto T, Tei C, Murayama M, Ichiyasu H, Hada Y. Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle: echocardiographic and ultrasono-cardiotomographic study. Jpn Heart J 1976;17(5):611-629.
29. Eriksson MJ, Sonnenberg B, Woo A, et al. Longterm outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;39(4): 638-645.
30. Webb JG, Sasson Z, Rakowski H, Liu P, Wigle ED. Apical hypertrophic cardiomyopathy: clinical followup and diagnostic correlates. J Am Coll Cardiol 1990;15(1):83-90.
31. Yamaguchi H, Ishimura T, Nishiyama S, et al. Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol 1979;44(3):401-412.
32. Moon JC, Fisher NG, McKenna WJ, Pennell DJ. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 2004; 90(6):645-649.
33. Suzuki J, Shimamoto R, Nishikawa J, et al. Morphological onset and early diagnosis in apical hypertrophic cardiomyopathy: a long term analysis with nuclear magnetic resonance imaging. J Am Coll Cardiol 1999;33(1):146-151.
34. Hansen MW, Merchant N. MRI of hypertrophic cardiomyopathy. II. Differential diagnosis, risk stratification, and posttreatment MRI appearances. AJR Am J Roentgenol 2007;189(6):1344-1352.
35. Fattori R, Rocchi G, Celletti F, Bertaccini P, Rapezzi C, Gavelli G. Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy. Am Heart J 1998;136(5):824-830.
36. Vogelsberg H, Mahrholdt H, Deluigi CC, et al. Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol 2008;51(10):1022-1030.
37. Vignaux O. Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol 2005;184(1): 249-254.
38. Maron BJ, Pelliccia A, Spirito P. Cardiac disease in young trained athletes: insights into methods for distinguishing athlete's heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation 1995;91(5):1596-1601.
39. Petersen SE, Selvanayagam JB, Francis JM, et al. Differentiation of athlete's heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2005;7(3): 551-558.
40. Moon JC, Sachdev B, Elkington AG, et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease: evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 2003;24(23):2151-2155.
41. Kato TS, Noda A, Izawa H, et al. Discrimination of nonobstructive hypertrophic cardiomyopathy from hypertensive left ventricular hypertrophy on the basis of strain rate imaging by tissue Doppler ultrasonography. Circulation 2004;110(25):3808-3814.
42. O'Hanlon R, Assomull RG, Prasad SK. Use of cardiovascular magnetic resonance for diagnosis and management in hypertrophic cardiomyopathy. Curr Cardiol Rep 2007;9(1):51-56.
43. Cooke JC, Cotton JM, Monaghan MJ. Mid-ventricular HOCM with apical asynergy. Heart 2000;83 (5):517.
44. Bergey PD, Axel L. Focal hypertrophic cardiomyopathy simulating a mass: MR tagging for correct diagnosis. AJR Am J Roentgenol 2000;174(1):242-244.
45. Binder J, Ommen SR, Gersh BJ, et al. Echocardiographyguided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations. Mayo Clin Proc 2006;81(4):459-467.
46. Germans T, Wilde AA, Dijkmans PA, et al. Structural abnormalities of the inferoseptal left ventricular wall detected by cardiac magnetic resonance imaging in carriers of hypertrophic cardiomyopathy mutations. J Am Coll Cardiol 2006;48(12):2518-2523.
47. Srichai MB, Hecht EM, Kim DC, Jacobs JE. Ventricular diverticula on cardiac CT: more common than previously thought. AJR Am J Roentgenol 2007;189(1):204-208.
48. Germans T, Nijveldt R, van Rossum AC. A more detailed view calls for more detailed definition: description of cardiac morphology with high-resolution CT and MRI. AJR Am J Roentgenol 2008;190 (2):W169.
49. Strijack B, Ariyarajah V, Soni R, et al. Late gadolinium enhancement cardiovascular magnetic resonance in genotyped hypertrophic cardiomyopathy with normal phenotype. J Cardiovasc Magn Reson 2008;10(1):58.
50. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000;342(24):1778-1785.
51. Grothues F, Smith GC, Moon JC, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002;90(1):29-34.
52. Devlin AM, Moore NR, Ostman-Smith I. A comparison of MRI and echocardiography in hypertrophic cardiomyopathy. Br J Radiol 1999;72(855): 258-264.
53. Maron MS, Olivotto I, Betocchi S, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med 2003;348(4):295-303.
54. Kofflard MJ, Ten Cate FJ, van der Lee C, van Domburg RT. Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. J Am Coll Cardiol 2003;41(6):987-993.
55. Biagini E, Coccolo F, Ferlito M, et al. Dilated-hypokinetic evolution of hypertrophic cardiomyopathy: prevalence, incidence, risk factors, and prognostic implications in pediatric and adult patients. J Am Coll Cardiol 2005;46(8):1543-1550.
56. Harris KM, Spirito P, Maron MS, et al. Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy. Circulation 2006;114(3):216-225.
57. Fighali S, Krajcer Z, Edelman S, Leachman RD. rogression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: higher incidence in patients with midventricular obstruction. J Am Coll Cardiol 1987;9(2):288-294.
58. Matsubara K, Nakamura T, Kuribayashi T, Azuma A, Nakagawa M. Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy. J Am Coll Cardiol 2003;42(2): 288-295.
59. Moon JC, Reed E, Sheppard MN, et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;43(12): 2260-2264.
60. Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003;41(9):1561-1567.
61. Kim RJ, Chen EL, Lima JA, Judd RM. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996;94(12):3318-3326.
62. Teraoka K, Hirano M, Ookubo H, et al. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. Magn Reson Imaging 2004;22(2): 155-161.
63. Choudhury L, Mahrholdt H, Wagner A, et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;40(12):2156-2164.
64. Kwon DH, Smedira NG, Rodriguez ER, et al. Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. J Am Coll Cardiol 2009;54(3): 242-249.
65. O'Gara PT, Bonow RO, Maron BJ, et al. Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography. Circulation 1987;76(6):1214-1223.
66. Camici P, Chiriatti G, Lorenzoni R, et al. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1991;17(4):879-886.
67. Sipola P, Lauerma K, Husso-Saastamoinen M, et al. First-pass MR imaging in the assessment of perfusion impairment in patients with hypertrophic cardiomyopathy and the Asp175Asn mutation of the a-tropomyosin gene. Radiology 2003;226(1): 129-137.